Bloomfield Hills, Michigan (PRWEB) May 29, 2013
Michigan-based CureLauncher (CureLauncher.com) today formally launched its patent-pending and proprietary clinical trial matching service that quickly and precisely determines the clinical trials that are best aligned with a person’s unique goals and conditions. The personalized service matches people to any of the 10,000 enrolling trials in the U.S. There is no cost associated with the service.
CureLauncher provides easy-to-understand information and supports people throughout the entire process – from considering a clinical trial to scheduling an appointment to meet the trial staff. For those dealing with a chronic disease, CureLauncher is their personal advocate.
Nearly 200 million Americans have a chronic disease such as diabetes, heart disease, asthma or cancer. Less than five percent of them know where to find new treatments available in clinical trials according to the Center for Information & Study on Clinical Research Participation (CISCRP).
“Sadly, very few people are aware how to benefit from these potentially life-changing trials or how to find trials that are right for their individual condition,” said Stephen Goldner, co-founder and CEO of CureLauncher. “CureLauncher redefines the approach to clinical trials by putting people and their families first. We always put the person first and help them find whatever new treatment matches their conditions.”
“No matter what stage of disease, you want to find all the options right from the beginning,” said Dr. Max Wicha, Director of the University of Michigan Comprehensive Cancer Center. “The very best treatment for someone may be in a clinical trial.”
There are nearly 10,000 new clinical trials enrolling in the United States right now. Each trial will be delayed an average of
Copyright©2012 Vocus, Inc.
All rights reserved